Diabetes Mellitus Type 2 Clinical Trial
Official title:
Impact of Non Surgical Periodontal Treatment on Glycemic Control in Type II Diabetics
Verified date | July 2013 |
Source | Pakistan Institute of Medical Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | Pakistan: Ministry of Health |
Study type | Interventional |
The purpose of this study is to determine the effects of non surgical periodontal treatment on glycemic control in type II diabetics.
Status | Active, not recruiting |
Enrollment | 184 |
Est. completion date | October 2013 |
Est. primary completion date | September 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 20 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Diagnosed patients of Type 2 Diabetes Mellitus for at least 2 years - HbA1C values >6.5 % as per ADA criteria - non smokers - Patients with at least 16 standing teeth - At least 8 teeth with one site having Mild to Moderate periodontal disease Exclusion Criteria: - Smokers - Type 2 Diabetics with complications e.g. renal, ophthalmic etc - Patients with chronic infections - Patients who get hospitalized or have to change their medications during the course of study |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Pakistan | Pakistan Institute of Medical Sciences | Islamabad | Federal Capital |
Lead Sponsor | Collaborator |
---|---|
Pakistan Institute of Medical Sciences |
Pakistan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Fasting Blood Glucose | Base Line, 3, 6 and 9 Months | No | |
Other | C-Reactive Protein | Base Line, 3 months, 6 months, 9 months | No | |
Primary | Change in HbA1C levels from base line at 3, 6 and 9 months | HbA1C levels will be recorded and any change in percentage noted | 3 months, 6 months, 9 months | No |
Secondary | Bleeding on Probing | a change in the above mentioned periodontal parameters will be recorded at the specified times Bleeding on probing will be recorded as Yes or No for each tooth | Base Line, 3 months, 6 months and 9 months | No |
Secondary | Clinical Attachment Loss | A change in the above mentioned periodontal parameter will be recorded at the specified times Clinical Attachment loss will be recorded in millimeters for each tooth | Base Line, 3 months, 6 months, 9 months | No |
Secondary | Periodontal Pocket Depth | A change in Periodontal pocket will be measured in millimeters for the above mentioned time frame | Base Line, 3 months, 6 months, 9 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01267448 -
Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia
|
Phase 4 | |
Active, not recruiting |
NCT05330247 -
Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study
|
N/A | |
Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 | |
Terminated |
NCT02373865 -
Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT01741181 -
Vitamin D Supplementation in Patients With Diabetes Mellitus Type 2
|
Phase 4 | |
Completed |
NCT01305434 -
Mulberry Leaf Extract and Blood Glucose Control in Diabetics
|
Phase 1/Phase 2 | |
Completed |
NCT01330121 -
Bridging the Gap by Transitional Care
|
N/A | |
Recruiting |
NCT00992797 -
Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity
|
Phase 2 | |
Completed |
NCT01580904 -
Impact of Pharmaceutical Care in Diabetics Patients
|
N/A | |
Active, not recruiting |
NCT00728403 -
Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 Diabetes
|
Phase 2 | |
Completed |
NCT00763815 -
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
|
Phase 3 | |
Active, not recruiting |
NCT00529815 -
Continuous Glucose Monitoring in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT00517465 -
A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.
|
Phase 1 | |
Completed |
NCT00119041 -
Diabetes Telemedicine Consultation: A Systems Improvement Intervention
|
N/A | |
Withdrawn |
NCT00417716 -
Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema
|
Phase 3 | |
Withdrawn |
NCT00600236 -
HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population
|
Phase 3 | |
Active, not recruiting |
NCT05887635 -
Study of Duodenal Mucosal RF Vapor Ablation in Subjects With Type-2 Diabetes Mellitus
|
N/A | |
Completed |
NCT03903965 -
Comparison of Retinal Perfusion Between Diabetic and Non-diabetic Patients With OCT Angiography After Cataract Surgery.
|
||
Completed |
NCT02666924 -
Cooking Classes for Chinese Canadian Patients Living With Diabetes
|
N/A | |
Recruiting |
NCT02501850 -
The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
|
Phase 4 |